...
首页> 外文期刊>Lung India >Suboptimal compliance to aerosol therapy in pediatric asthma: A prospective cohort study from Eastern India
【24h】

Suboptimal compliance to aerosol therapy in pediatric asthma: A prospective cohort study from Eastern India

机译:小儿哮喘对气雾剂治疗的不佳依从性:来自印度东部的一项前瞻性队列研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Suboptimal compliance to aerosol medication is common in pediatric asthma. Accordingly, the objective of this study is to assess noncompliance to aerosol therapy in childhood asthma and determine contributory factors. Materials and Methods: A prospective cohort study was conducted among pediatric patients attending asthma clinic. Patients (n = 215) having “mild” and “moderate” asthma severity rating were included. The total study duration was 12 months (June 2016–June 2017), with an active recruitment phase of 6 months. The minimum period for follow-up was 90 days. Caregivers were instructed to maintain an “asthma diary” for daily dosages of inhalers. At follow-up, the diary entries were corroborated with the amount of inhaler medication unused. Subsequently, medication compliance ratio (CR) was calculated according to the following formula: CR = number of medication doses takenumber of medication doses prescribed. CR% 80 was considered as “good compliance”. Results: A total of 169 patients (78.6%) returned for follow-up. The mean compliance to asthma medication was suboptimal (75.3%). The children were primarily prescribed inhaled corticosteroids and short-acting beta-agonist (SABA)-based regimens on index visit. Leukotriene receptor antagonist was added in select cases (67.9%). Nearly 45.6% of the patients had “good compliance.” CR correlated with the sociodemographic profile and disease severity. Higher socioeconomic status and proper inhaler technique reflected better symptom control. Fear of side effects, behavioral difficulties, and economic restrictions were the identified causes of medication default. Conclusion: In the Eastern part of India, compliance to aerosol therapy in pediatric asthma is suboptimal. Sociodemographics, disease severity, and inhaler technique are important determinants.
机译:背景:在儿童哮喘中,对气雾剂药物的依从性不佳很常见。因此,本研究的目的是评估儿童哮喘中对气雾剂治疗的不依从性并确定影响因素。资料与方法:前瞻性队列研究在哮喘门诊的儿科患者中进行。包括“轻度”和“中度”哮喘严重程度等级的患者(n = 215)。研究总时间为12个月(2016年6月至2017年6月),有效招募阶段为6个月。随访的最短时间为90天。指导护理人员维持每日吸入剂量的“哮喘日记”。在随访中,日记条目与未使用的吸入药物的量有关。随后,根据以下公式计算药物依从率(CR):CR =服用的药物剂量数/处方的药物剂量数。 CR%> 80被认为是“良好合规性”。结果:共有169例患者(78.6%)返回随访。对哮喘药物的平均依从性不佳(75.3%)。在索引访视时,主要为儿童开具吸入糖皮质激素和基于短效β受体激动剂(SABA)的治疗方案。在某些病例中添加了白三烯受体拮抗剂(67.9%)。近45.6%的患者“依从性良好”。 CR与社会人口统计学特征和疾病严重程度相关。较高的社会经济地位和适当的吸入器技术反映出较好的症状控制。担心副作用,行为困难和经济限制是确定用药违约的原因。结论:在印度东部,对儿童哮喘气雾疗法的依从性欠佳。社会人口统计学,疾病严重程度和吸入技术是重要的决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号